Mortensen, A. C. L.
Berglund, H.
Segerström, L.
Walle, M.
Hofström, C.
Persson, H.
Nygren, P.-Å.
Nilvebrant, J.
Frejd, F. Y.
Nestor, M.
Funding for this research was provided by:
Cancerfonden
Svenska Sällskapet för Medicinsk Forskning
Vetenskapsrådet
VINNOVA
Barncancerfonden
Karolinska Institute
Article History
Received: 17 July 2023
Accepted: 20 November 2023
First Online: 24 November 2023
Competing interests
: AM, FF and MN are co-founders of Akiram Therapeutics AB, which holds the patent for the antibody (UU-40) described in this study. None of the additional authors have competing interests.